Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

#ASH2024

Home » #ASH2024
ASH 2024 | Dr. Qian Jiang: Groundbreaking Leukemia Research and the Future of the Field

ASH 2024 | Dr. Qian Jiang: Groundbreaking Leukemia Research and the Future of the Field

Posted by By Peng Longmei 2024.12.31
Editor's Note: The 66th Annual Meeting of the American Society of Hematology (ASH) took place in San Diego from December 7 to 10, 2024. This global event brought together leading…
Read More
ASH 2024 | Dr. Wenming Chen: Precision and Immune-Targeted Therapies to Overcome R/R MM Challenges

ASH 2024 | Dr. Wenming Chen: Precision and Immune-Targeted Therapies to Overcome R/R MM Challenges

Posted by By Mourabit Halima 2024.12.31
Editor's Note: The 66th Annual Meeting of the American Society of Hematology (ASH) took place in San Diego from December 7 to 10, 2024. This prestigious event brought together global…
Read More
Recent Posts
  • Professor Haihong Wang: UNION TNT Study Highlights the Potential of Precision Combination Therapy for HER2-Expressing Locally Advanced Rectal Cancer
  • Professor Yi Yi Yu: Building a High-Quality IIT Research System at Zhongshan Hospital
  • Pujiang Prostate Cancer Summit | Professor Jianming Guo: Breaking Through CRPC Resistance and Why Cytoreductive Surgery for Oligometastatic Disease Is Emerging as the Next Frontier
  • Pujiang Prostate Cancer Summit | Professor Dingwei Ye: Expanding Early Screening, Standardizing Care, and Advancing Clinical Research—Three Pillars to Narrow China’s Prostate Cancer Survival Gap
  • Clear Horizons, Comprehensive Urologic Care | Professor Xin Yao: ADT Remains the Cornerstone of Prostate Cancer Management, While LHRH Antagonists Deliver Both Clinical Efficacy and Quality of Life
Recent Comments
    Archives
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top